Abbott Laboratories (ABT) Share Price ($):36.31 Price Change: -0.34 (-0.93%)

Expand Company Information
Volume 8,053,821 Avg Volume 11,023,419
Day's Low $36.19 Day's High $36.55
52-wk Low $28.25 52-wk High $36.89
Previous Close $36.65 Open Price $36.37
Dividend $ 0.14 Yield 1.54%
Market Cap 57,565,300,000 P/E (Forward) 18.14
Chart for ABT
Exchange: NYSE Industry: Pharmaceuticals & Biotechnology Last Trade: 4:04 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Find a Broker »
    Article Time Date Source
    U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH 8:52 AM Apr 5, 2013 Dow Jones Global News Select
    UPDATE: U.S. Appeals Court Reverses $593 Million Award Against J&J 4:49 PM Apr 4, 2013 Dow Jones Global News Select
    Appeals Court Reverses $593 Million Award Against J&J 4:45 PM Apr 4, 2013 Dow Jones Global News Select
    Court Reverses Award Against J&J 4:24 PM Apr 4, 2013  WSJ.com
    U.S. Appeals Court Reverses $593 Million Award Against J&J 4:09 PM Apr 4, 2013 Dow Jones Global News Select
    Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics 8:02 AM Apr 2, 2013  PR
    Abbott Hosts Conference Call for First-Quarter Earnings 8:29 AM Apr 1, 2013  PR
    New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues 8:01 AM Mar 28, 2013  PR
    Low-Quality Stocks Have Zoomed. Time to Shift Gears? 6:23 PM Mar 22, 2013  WSJ.com
    UPDATE: Abbott Labs Issues Safety Alert on MitraClip Heart-Valve Device 3:55 PM Mar 22, 2013 Dow Jones Global News Select
    Abbott Labs Issues Safety Alert on MitraClip Heart-Valve Device 3:35 PM Mar 22, 2013 Dow Jones Global News Select
    The Morning Ledger: 'Pay for Performance' Taking Root 6:53 AM Mar 21, 2013  WSJ.com
    FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip(R) Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery 7:44 PM Mar 20, 2013  PR
    Longstanding Pay Practices Under Attack 7:26 PM Mar 20, 2013  WSJ.com
    FDA Panel Votes 5-3 on Abbott Device 6:49 PM Mar 20, 2013  WSJ.com
    FDA Panel Votes 5-3 on Benefits of Abbott Heart Device Mitraclip 6:44 PM Mar 20, 2013 Dow Jones Global News Select
    UPDATE: AbbVie CEO 2012 Pay Up 40%, but Lags General Counsel's Total 3:02 PM Mar 18, 2013 Dow Jones Global News Select
    Setback for Abbott's Mitraclip Heart Device 12:51 PM Mar 18, 2013  WSJ.com
    AbbVie CEO's Compensation Up More Than 40% 11:40 AM Mar 18, 2013  WSJ.com
    UPDATE: FDA Recommends Against Approving Abbott's Mitraclip Heart Device 11:36 AM Mar 18, 2013 Dow Jones Global News Select
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools